經(jing)中國證(zheng)監(jian)會(hui)核準，公(gong)(gong)司于(yu)2014年6月20日(ri)向社會(hui)公(gong)(gong)開發行(xing)(xing)了(le)631.76萬(wan)張可轉(zhuan)換公(gong)(gong)司債(zhai)券，每張面(mian)值100元(yuan)，發行(xing)(xing)總額(e)63,176.00萬(wan)元(yuan)。扣除(chu)承銷(xiao)費(fei)、保薦費(fei)等發行(xing)(xing)費(fei)用后，本次募(mu)集資(zi)金凈額(e)為61,597.88萬(wan)元(yuan)。經(jing)深(shen)圳(zhen)證(zheng)券交易所同意(yi)，公(gong)(gong)司63,176.00萬(wan)元(yuan)可轉(zhuan)換公(gong)(gong)司債(zhai)券已于(yu)2014年7月9日(ri)在深(shen)圳(zhen)證(zheng)券交易所掛牌交易，債(zhai)券簡稱“長青(qing)轉(zhuan)債(zhai)”，債(zhai)券代碼(ma)“128006”。

 公司(si)本(ben)次發行(xing)的(de)可轉(zhuan)(zhuan)換公司(si)債券存續(xu)期為6年(nian)(nian)(nian)(nian)，自2014年(nian)(nian)(nian)(nian)6月(yue)20日(ri)至(zhi)2020年(nian)(nian)(nian)(nian)6月(yue)19日(ri)。票面利(li)率第(di)(di)(di)一年(nian)(nian)(nian)(nian)0.6%、第(di)(di)(di)二年(nian)(nian)(nian)(nian)0.9%、第(di)(di)(di)三(san)年(nian)(nian)(nian)(nian)1.2%、第(di)(di)(di)四年(nian)(nian)(nian)(nian)1.6%、第(di)(di)(di)五年(nian)(nian)(nian)(nian)2.0%、第(di)(di)(di)六年(nian)(nian)(nian)(nian)2.5%。每(mei)年(nian)(nian)(nian)(nian)付息(xi)一次。“長青轉(zhuan)(zhuan)債”初始轉(zhuan)(zhuan)股價格13.48元(yuan)/股，轉(zhuan)(zhuan)股期自2014年(nian)(nian)(nian)(nian)12月(yue)29日(ri)至(zhi)2020年(nian)(nian)(nian)(nian)6月(yue)19日(ri)。本(ben)次募集(ji)資(zi)金凈(jing)額將(jiang)用于投資(zi)七(qi)個(ge)項(xiang)目(mu)(mu)，即年(nian)(nian)(nian)(nian)產(chan)3000噸S-異丙甲草胺原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)300噸氰氟草酯原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)300噸環氧菌唑原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)1000噸啶蟲脒原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)200噸茚(yin)蟲威原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)450噸醚苯磺隆原(yuan)藥(yao)項(xiang)目(mu)(mu)、年(nian)(nian)(nian)(nian)產(chan)1000噸2-苯并(bing)呋喃酮中間體項(xiang)目(mu)(mu)，項(xiang)目(mu)(mu)達產(chan)后，每(mei)年(nian)(nian)(nian)(nian)可新增營業(ye)收(shou)入8.40億元(yuan)，新增凈(jing)利(li)潤1.04億元(yuan)，公司(si)的(de)盈(ying)利(li)水平將(jiang)得到(dao)進一步提升。

公(gong)司(si)(si)本次可轉換(huan)公(gong)司(si)(si)債券的成功發(fa)(fa)行，無疑使(shi)公(gong)司(si)(si)的發(fa)(fa)展(zhan)(zhan)基礎更(geng)(geng)加厚(hou)實(shi)，同時也(ye)獲得(de)了更(geng)(geng)為(wei)廣闊的發(fa)(fa)展(zhan)(zhan)空(kong)間(jian)，推進公(gong)司(si)(si)進入新的發(fa)(fa)展(zhan)(zhan)階段，公(gong)司(si)(si)也(ye)將(jiang)(jiang)緊(jin)緊(jin)把握(wo)機遇，堅持高起點、高標(biao)準實(shi)施好七個(ge)募集資(zi)金項目建(jian)設，從而(er)使(shi)公(gong)司(si)(si)的生(sheng)產規(gui)模(mo)、市(shi)場競(jing)爭力、抗風(feng)險(xian)能(neng)力等都將(jiang)(jiang)得(de)到(dao)較大幅度的提升，為(wei)客(ke)戶、股(gu)東、員工及社會(hui)創造超值回報！